Niraparib is a relatively strong DAT inhibitor with IC50 value of 51 nM (Table 5); meanwhile DAT as a dopamine transporter has a clear role in schizophrenia and deliria (Hahn and Blakely, 2002), therefore it is common neurologic disorder observed with niraparib. Here, SLC6A3 is linked to nervous system disorder.